50 participants
A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-06-09
- Start Date:
- 2012-10-16
- Completion:
- 2015-04-04
Conditions
- Colorectal Cancer
Interventions
- DRUG